コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 proven track record of clinical translation, poly(lactic-co-glycolic) acid.
2 orant, surfactant, and plasticizer solvents, polylactic-co-glycolic acid (30% by solids volume), and
3 penicillamine (SNAP) was encapsulated within poly(lactic-co-glycolic acid) 50:50 (PLGA) microspheres
5 noparticle (NP) system containing a blend of poly(lactic-co-glycolic acid) and a representative poly(
6 produces particles that perform better than poly(lactic-co-glycolic acid) and iron oxide, two common
7 The emulsification of diblock copolymers of poly(lactic-co-glycolic acid) and polyethylene glycol (P
8 aried from 0% to 50% (w/w) sirolimus drug in poly(lactic-co-glycolic acid) and were prepared on both
9 meter were fabricated by emulsification with poly(lactic-co-glycolic acid) as a core material and, in
10 nanorod; PEG = poly(ethylene glycol); PLGA = poly(lactic-co-glycolic acid)) assembled from small AuNR
11 sed the effect of thermosensitive hydrogels (poly(lactic-co-glycolic acid)-b-poly(ethylene glycol)-b-
12 were engineered using biodegradable diblock poly(lactic-co-glycolic acid)-b-polyethyleneglycol and p
13 c-co-glycolic acid)-b-polyethyleneglycol and poly(lactic-co-glycolic acid)-b-polyethyleneglycol colla
14 ]palladium(II) dichloride in a biocompatible poly(lactic-co-glycolic acid)-b-polyethyleneglycol platf
15 clinically relevant parameters, we report a poly(lactic-co-glycolic acid) based curcumin nanoparticl
16 ric nanoparticle (NP) based on biodegradable poly(lactic-co-glycolic acid)-block-polyethyleneglycol f
17 onstrated that carboxyl functionalization of poly(lactic-co-glycolic acid) can achieve great material
18 s HDL mimic contains a core of biodegradable poly(lactic-co-glycolic acid), cholesteryl oleate, and a
19 syndiotactic, and atactic repeating sequence poly(lactic-co-glycolic acid) copolymers (RSC PLGAs) wer
22 tem, cell-penetrating peptide (CPP)-assisted poly(lactic-co-glycolic acid nanoparticles (PLGA NPs), f
23 utic carriers such as FDA approved pegylated poly(lactic-co-glycolic acid) nanoparticles (PLGA-PEG-NP
24 f peanut oral immunotherapy using CpG-coated poly(lactic-co-glycolic acid) nanoparticles containing p
27 fically, biodegradable poly(ethylene glycol)-poly(lactic-co-glycolic acid) (PEG-PLGA) microparticles
28 taining neural growth factor (PCL-NGF) and a poly(lactic-co-glycolic acid) pellet containing glutamin
29 eated by encapsulating econazole-impregnated poly(lactic-co-glycolic) acid (PLGA) films in poly(hydro
31 nd characterize micrometer-sized agent-doped poly(lactic-co-glycolic) acid (PLGA) particles by using
32 BCNU, Carmustine) into biodegradable polymer poly(lactic-co-glycolic) acid (PLGA) using an electrojet
33 receptor 4 (TLR4) and TLR7/8 encapsulated in poly(lactic-co-glycolic) acid (PLGA)-based nanoparticles
38 We formulated particulate nanocarriers using poly(lactic-co-glycolic acid) (PLGA) and PLGA-polyethyle
39 iphasic matrix consisting of water-insoluble poly(lactic-co-glycolic acid) (PLGA) and water-soluble p
40 thod to microencapsulate vaccine antigens in poly(lactic-co-glycolic acid) (PLGA) by simple mixing of
41 odegradable nanoparticles composed of PSA or poly(lactic-co-glycolic acid) (PLGA) diffused at least 3
42 vaginal administration with nanoparticles of poly(lactic-co-glycolic acid) (PLGA) encapsulating short
45 coating consists of 25% (w/w) sirolimus in a poly(lactic-co-glycolic acid) (PLGA) matrix and is spray
46 regeneration, was encapsulated in degradable poly(lactic-co-glycolic acid) (PLGA) microparticles embe
48 terned within the scaffolds and accommodated poly(lactic-co-glycolic acid) (PLGA) microparticulate sy
50 of the study was to evaluate the ability of poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NP)
52 tingly, encapsulation of the compound within poly(lactic-co-glycolic acid) (PLGA) nanoparticles (PLGA
56 e sought to test how surface modification of poly(lactic-co-glycolic acid) (PLGA) nanoparticles with
60 composed of either the biodegradable polymer poly(lactic-co-glycolic acid) (PLGA) or the biocompatibl
61 sought to test the hypothesis that inhalable poly(lactic-co-glycolic acid) (PLGA) particles of silden
63 script, we describe microspheres composed of poly(lactic-co-glycolic acid) (PLGA) that can encapsulat
65 ch for "barcoding" nanoparticles composed of poly(lactic-co-glycolic acid) (PLGA) with bright, spectr
66 ridone was chosen as a model therapeutic and poly(lactic-co-glycolic acid) (PLGA) with similar molecu
67 he hydrolysis profile for the degradation of poly(lactic-co-glycolic acid) (PLGA), a member of the mo
68 lly prepared by encapsulation of the drug in poly(lactic-co-glycolic acid) (PLGA), a polymer that is
70 e NP with a diameter of 227nm, composed of a poly(lactic-co-glycolic acid) (PLGA)-based core coated w
71 end of polymers with distinct functions: (i) poly(lactic-co-glycolic acid) (PLGA, P) serving as the m
72 copolymer composed of end-to-end linkage of poly(lactic-co-glycolic-acid) (PLGA), polyethyleneglycol
73 N microparticle formulations as well as with poly(lactic-co-glycolic acid)(PLGA)-based microparticles
74 -co-glycolic acid)-b-poly(ethylene glycol)-b-poly(lactic-co-glycolic acid); PLGA-PEG-PLGA) for increa
75 onic peptides and low Mw free acid end-group poly(lactic-co-glycolic acids) (PLGAs) used to achieve c
76 arriers consist of poly(butylcyanoacrylate), poly(lactic-co-glycolic acid), poly(lactic acid) NPs, li
77 es when co-cultured on hydroxyapatite-coated poly(lactic-co-glycolic acid)/poly(L-lactic acid) (HA-PL
79 ng hMSCs incorporated in a uniquely designed poly(lactic-co-glycolic) acid scaffold, a clinically saf
80 glycol with polylysine around a salt-leached polylactic-co-glycolic acid scaffold that is degraded in
81 three-dimensional (3D)-printed biodegradable poly(lactic-co-glycolic acid) scaffolds (PLGA), and hydr
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。